跳至主要内容
临床试验/NCT04142814
NCT04142814撤回不适用

Randomized Controlled Study on the Evaluation of the T-PEP Method Based on Positive Expiratory Pressure Versus Intrapulmonary Percussive Ventilation for Lower Respiratory Airways Clearance in Sub-acute, Tetraplegic, Tracheotomized Spinal Cord Injured Patients

Montecatone Rehabilitation Institute S.p.A.1 个研究点 分布在 1 个国家开始时间: 2022年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Incidence of adverse events

研究概览

简要总结

In tetraplegic patients with complete cervical spinal cord injury, respiratory complications are very frequent, especially in the sub-acute phase: the lungs often become obstructed due to the accumulation of secretions and the contemporary inefficiency of the cough mechanism. The present pilot study aims, in the context of a rehabilitative Critical Care Unit, at evaluating a not yet published method, called "T-PEP" and based on the principle of Positive Expiratory Pressure, applicable to tracheotomised and mechanically ventilated patients. This method, conceptually simple and low cost, is compared with a known method based on the principle of Percussive Intrapulmonary Ventilation (IPV). Safety and efficacy issues are covered.

详细描述

Respiratory complications are very frequent, especially in the sub-acute phase following a spinal cord injury and must be treated to avoid even very serious outcomes. In the patient with a complete cervical spinal cord injury (and therefore tetraplegic, from a motor perspective), the lungs often become obstructed due to the accumulation of secretions and the contemporary inefficiency of the physiological mechanism of the cough. Various methods for bronchial clearance are known, but when the patient is tracheotomized and the secretions accumulate in the deepest part of the lung, nowadays the only described method available to mobilize such secretions and allow more efficient respiratory exchanges is based on the principle of Percussive Intrapulmonary Ventilation (IPV). It requires a special device, equipped with a pneumatic air generator, connected to the tracheal cannula. Such treatment needs the assistance of highly trained and expert operators, moreover IPV is a quite complex and expensive technique which has to be applied in a prudential manner in such tetraplegic patients, especially because they show significant hemodynamic instability in the acute/sub-acute phase after the spinal cord lesion.

The principle of Positive Expiratory Pressure (PEP) is already known for its efficacy in the secretions' clearance of the lower respiratory airways in other pathological conditions. However, in its classic modalities, it requires the preservation of the functionality of the respiratory muscles. To circumvent this limit in tetraplegic and tracheotomized patients, a respiratory physiotherapeutic procedure called "T-PEP" has been developed at the Montecatone Rehabilitation Institute. Such method is conceptually simple and low cost, it requires the manual assistance of a trained physiotherapist and the use of some components of common use in the clinical practice of Critical Care Units.

The present pilot randomized controlled trial aims at comparing the T-PEP and IPV methods, assigned to 2 parallel arms (1:1 allocation ratio), in the context of the Critical Care Unit of the Montecatone Rehabilitation Institute hospital, in sub-acute, tetraplegic, tracheotomized, mechanically ventilated, spinal cord injured patients. The trial covers safety and efficacy issues; cognitive performances are also addressed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •spinal cord injury due to traumatic or non-traumatic etiology;
  • •neurological level from C4 to C7 (included)
  • •complete spinal cord injury, classifiable as "A" grade according to the Asia Impairment Scale (AIS);
  • •distance from the spinal cord injury event from 1 to 5 weeks;
  • •first admission to Montecatone R.I. (in particular to the Critical Care Unit);
  • •patients with middle-basal hypoventilation;
  • •patients in partial or continuous mechanical ventilation;
  • •patients with tracheotomy;
  • •patients capable of giving meaningful consent;
  • •collaborating patients.

排除标准

  • •thoracic trauma with non-drained thoracic fractures and / or pneumothorax and / or hemorrhage;
  • •pleural effusion;
  • •significant hemodynamic instability needing amines administration and / or Shock Index > 1.5;
  • •patients with tracheoesophageal fistulae;
  • •patients with severe acquired brain injury;
  • •patients with ongoing sepsis;
  • •patients with ongoing pregnancy.

研究组 & 干预措施

T-PEP

Experimental

Each T-PEP session includes 10 inspiratory/expiratory cycles, repeated 3 times and interspersed by a pause of about 3 minutes.

Each session will be immediately followed by bronchoaspiration and/or Mechanical Insufflation-Exsufflation (MI-E).

Sessions will take place at least twice a day for a number of days until the attainment of an effective pulmonary ventilation (as detected by thoracic auscultation), then continued for a further 3 days (at least 2 times a day) for the outcome stabilization, as confirmed also by arterial-blood gas test (ABG), spirometry, chest X-ray and chest ultrasound.

T-PEP sessions will take place at least 1 hour after meals or nutrition via nasogastric tube.

Tracheal cannula will be kept constantly cuffed during the sessions. Ipratropium Bromide treatment will be on place from study entry until at least 4 weeks after the attainment of a stabilized effective pulmonary ventilation.

干预措施: T-PEP (Procedure)

IPV

Active Comparator

Each IPV session includes 3 treatment cycles, interspersed with a pause, consisting of a first high-frequency steps, lasting about 5 minutes, immediately followed by a second low-frequency step lasting approximately one minute.

Each session will be immediately followed by bronchoaspiration and/or Mechanical Insufflation-Exsufflation (MI-E).

Sessions will take place at least twice a day for a number of days until the attainment of an effective pulmonary ventilation (by thoracic auscultation), then continued for a further 3 days (at least 2 times a day) for outcome stabilization, as confirmed by ABG test, spirometry, chest X-ray and chest ultrasound.

IPV sessions will take place at least 1 hour after meals or nutrition via nasogastric tube.

Tracheal cannula will be kept constantly cuffed during the sessions. Ipratropium Bromide treatment will be on place from study entry until at least 4 weeks, after the attainment of a stabilized effective pulmonary ventilation.

干预措施: IPV (Procedure)

结局指标

主要结局

Incidence of adverse events

时间窗: Through the whole period of clearance treatment to attain a stabilized effective pulmonary ventilation (whole period length is 2 weeks on average) until the following 4 weeks

Incidence of adverse events in the treatment period and during the subsequent follow-up, directly correlated with the lower airways cleaning treatments under investigation

次要结局

  • Evaluation of cognitive performance: logical and executive functions - 3(Day of attainment of stabilized effective pulmonary ventilation; 4 weeks after the day of attainment of stabilized effective pulmonary ventilation; 3 months after the day of attainment of stabilized effective pulmonary ventilation)
  • Time needed for attainment of a stabilized effective pulmonary ventilation(Through the whole period of clearance treatment to attain a stabilized effective pulmonary ventilation (whole period length is 2 weeks on average))
  • Recurrence of lower airways obstruction(From the attainment of stabilized effective pulmonary ventilation until 3 months later)
  • Incidence of infections of lower respiratory airways(Through the whole period of clearance treatment to attain a stabilized effective pulmonary ventilation (whole period length is 2 weeks on average) and through the following 3 months)
  • Evaluation of cognitive performance: attention and memory - 2(Baseline (initial visit); day of attainment of stabilized effective pulmonary ventilation; 4 weeks after the day of attainment of stabilized effective pulmonary ventilation; 3 months after the attainment of stabilized effective pulmonary ventilation)
  • Evaluation of cognitive performance: attention and memory - 4(Baseline (initial visit); day of attainment of stabilized effective pulmonary ventilation; 4 weeks after the day of attainment of stabilized effective pulmonary ventilation; 3 months after the attainment of stabilized effective pulmonary ventilation)
  • Incidence of sepsis(Through the whole period of clearance treatment to attain a stabilized effective pulmonary ventilation (whole period length is 2 weeks on average) and through the following 3 months)
  • Evaluation of cognitive performance: attention and memory - 3(Baseline (initial visit); day of attainment of stabilized effective pulmonary ventilation; 4 weeks after the day of attainment of stabilized effective pulmonary ventilation; 3 months after the attainment of stabilized effective pulmonary ventilation)
  • Evaluation of cognitive performance: logical and executive functions - 1(Day of attainment of stabilized effective pulmonary ventilation; 4 weeks after the day of attainment of stabilized effective pulmonary ventilation; 3 months after the day of attainment of stabilized effective pulmonary ventilation)
  • Time needed for weaning from mechanical ventilation, from hospital admission(From admission date to Montecatone R.I. until mechanical ventilation end date (up to 1 year))
  • Evaluation of cognitive performance: attention and memory - 1(Baseline (initial visit); day of attainment of stabilized effective pulmonary ventilation; 4 weeks after the day of attainment of stabilized effective pulmonary ventilation; 3 months after the attainment of stabilized effective pulmonary ventilation)
  • Time needed for weaning from mechanical ventilation, from its start(From mechanical ventilation start date until mechanical ventilation end date (up to 1 year))
  • Evaluation of cognitive performance: logical and executive functions - 2(Day of attainment of stabilized effective pulmonary ventilation; 4 weeks after the day of attainment of stabilized effective pulmonary ventilation; 3 months after the day of attainment of stabilized effective pulmonary ventilation)
  • Costs of the T-PEP and IPV treatments - 1(Through the whole period of clearance treatment to attain a stabilized effective pulmonary ventilation (whole period length is 2 weeks on average))
  • Evaluation of cognitive performance: social cognition(3 months after the day of attainment of stabilized effective pulmonary ventilation)
  • Costs of the T-PEP and IPV treatments - 2(Through the whole period of clearance treatment to attain a stabilized effective pulmonary ventilation (whole period length is 2 weeks on average))

研究者

发起方
Montecatone Rehabilitation Institute S.p.A.
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验